Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation-based Assays for Detecting Disease Spread in Rhabdomyosarcoma

NCT01419509 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01419509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01419509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation-based Assays for Detecting Disease Spread in Rhabdomyosarcoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
May 31, 2016
Enrollment
170 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma